Document Detail


Auto-antibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction.
MedLine Citation:
PMID:  22061093     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objectives:  To explore the diagnostic accuracies of anti-apolipoproteinA-1 (anti-ApoA-1) IgG and anti-phosphorylcholine (anti-PC) IgM alone, expressed as a ratio (anti-ApoA-1 IgG/anti-PC IgM), and combined with the TIMI score for non-ST-segment elevation myocardial infarction (NSTEMI) (NSTEMI-TIMI score) to create a new diagnostic algorithm - the Clinical Autoantibody Ratio (CABR) score - for diagnosis of NSTEMI and subsequent cardiac troponin I (cTnI) elevation in patients with acute chest pain (ACP). Methods:  In this single-centre prospective study, 138 patients presented at the emergency department with ACP without ST-segment elevation myocardial infarction. Anti-ApoA-1 IgG and anti-PC IgM were assessed by enzyme-linked immunosorbent assay on admission. Post-hoc determination of the CABR score cut-off was performed by receiver operating characteristics analyses. Results:  The adjudicated final diagnosis was NSTEMI in 17% (24/138) of patients. Both auto-antibodies alone were found to be significant predictors of NSTEMI diagnosis, but the CABR score had the best diagnostic accuracy (area under the curve [AUC]: 0.88; 95% confidence interval [CI]: 0.82-0.95). At the optimal cut-off of 3.3, the CABR score negative predictive value (NPV) was 97% (95% CI: 90-99). Logistic regression analysis showed that a CABR score >3.3 increased the risk of subsequent NSTEMI diagnosis 19-fold (odds ratio: 18.7; 95% CI: 5.2-67.3). For subsequent cTnI positivity, only anti-ApoA-1 IgG and CABR score displayed adequate predictive accuracies with AUCs of 0.80 (95% CI: 0.68-0.91) and 0.82 (95% CI: 0.70-0.94), respectively; the NPVs were 95% (95% CI: 90-98) and 99% (95% CI: 94-100), respectively. Conclusion:  The CABR score, derived from adding the anti-ApoA-1 IgG/anti-PC IgM ratio to the NSTEMI-TIMI score, could be a useful measure to rule out NSTEMI in patients presenting with ACP at the emergency department without electrocardiographic changes.
Authors:
Pierre-Frederic Keller; Sabrina Pagano; Pascale Roux-Lombard; Philippe Sigaud; Olivier T Rutschmann; Mach François; Hochstrasser Denis; Nicolas Vuilleumier
Related Documents :
16756773 - Left atrial emptying fraction correlation with vascular pedicle width in patients with ...
16268983 - The effects of left ventricular hypertrophy on the respiratory changes in transmitral d...
133123 - Diagnostic echocardiography in the adult.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-7
Journal Detail:
Title:  Journal of internal medicine     Volume:  -     ISSN:  1365-2796     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8904841     Medline TA:  J Intern Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 The Association for the Publication of the Journal of Internal Medicine.
Affiliation:
Division of Cardiology Department of Internal Medicine, Geneva University Hospitals, Switzerland. Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospitals, Switzerland. Division of Immunology and Allergy, Department of Internal Medicine, Geneva University Hospitals, Switzerland. Division of Emergency, Department of Primary Care, Geneva University Hospitals, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Processing and nutritional characteristics of value added ostrich products.
Next Document:  ESR1 in myocardial infarction.